| Optimizing the discovery organization for innovation. | |
| | |
MedLine Citation:
|
PMID: 16055021 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Strategic management is the process of adapting organizational structure and management principles to fit the strategic goal of the business unit. The pharmaceutical industry has generally been expert at optimizing its organizations for drug development, but has rarely implemented different structures for the early discovery process, where the objective is innovation and the transformation of innovation into drug projects. Here, a set of strategic management methods is proposed, covering team composition, organizational structure, management principles and portfolio management, which are designed to increase the level of innovation in the early drug discovery process. |
| | |
Authors:
|
Frank Sams-Dodd |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Drug discovery today Volume: 10 ISSN: 1359-6446 ISO Abbreviation: Drug Discov. Today Publication Date: 2005 Aug |
Date Detail:
|
Created Date: 2005-08-01 Completed Date: 2005-08-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9604391 Medline TA: Drug Discov Today Country: England |
Other Details:
|
Languages: eng Pagination: 1049-56 Citation Subset: IM |
Affiliation:
|
Boehringer Ingelheim Pharma GmbH, D-88397 Biberach a.d. Riss, Germany. Frank.Sams-Dodd@bc.boehringer-ingelheim.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Central Nervous System Agents
/
pharmacology Drug Design Drug Industry / organization & administration* Models, Organizational Organizational Objectives |
| Chemical | |
Reg. No./Substance:
|
0/Central Nervous System Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer.
Next Document: How many genomics targets can a portfolio afford?